BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 30358158)

  • 1. Highly Efficient CRISPR-Cas9-Mediated Genome Editing in Human Pluripotent Stem Cells.
    Maguire JA; Cardenas-Diaz FL; Gadue P; French DL
    Curr Protoc Stem Cell Biol; 2019 Feb; 48(1):e64. PubMed ID: 30358158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly Efficient CRISPR/Cas9-Mediated Genome Editing in Human Pluripotent Stem Cells.
    Maguire JA; Gadue P; French DL
    Curr Protoc; 2022 Nov; 2(11):e590. PubMed ID: 36426905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR/Cas9-based Targeted Genome Editing for the Development of Monogenic Diseases Models with Human Pluripotent Stem Cells.
    Gupta N; Susa K; Yoda Y; Bonventre JV; Valerius MT; Morizane R
    Curr Protoc Stem Cell Biol; 2018 May; 45(1):e50. PubMed ID: 30040245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient, footprint-free human iPSC genome editing by consolidation of Cas9/CRISPR and piggyBac technologies.
    Wang G; Yang L; Grishin D; Rios X; Ye LY; Hu Y; Li K; Zhang D; Church GM; Pu WT
    Nat Protoc; 2017 Jan; 12(1):88-103. PubMed ID: 27929521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR-Cas9-Based Genome Editing of Human Induced Pluripotent Stem Cells.
    Giacalone JC; Sharma TP; Burnight ER; Fingert JF; Mullins RF; Stone EM; Tucker BA
    Curr Protoc Stem Cell Biol; 2018 Feb; 44():5B.7.1-5B.7.22. PubMed ID: 29512106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive Protocols for CRISPR/Cas9-based Gene Editing in Human Pluripotent Stem Cells.
    Santos DP; Kiskinis E; Eggan K; Merkle FT
    Curr Protoc Stem Cell Biol; 2016 Aug; 38():5B.6.1-5B.6.60. PubMed ID: 27532820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR-Cas9 Genome Editing in Drosophila.
    Gratz SJ; Rubinstein CD; Harrison MM; Wildonger J; O'Connor-Giles KM
    Curr Protoc Mol Biol; 2015 Jul; 111():31.2.1-31.2.20. PubMed ID: 26131852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome Engineering for Stem Cell Transplantation.
    Argani H
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):31-37. PubMed ID: 30777520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR-Cas9-Mediated Genome Editing in Leishmania donovani.
    Zhang WW; Matlashewski G
    mBio; 2015 Jul; 6(4):e00861. PubMed ID: 26199327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precise and efficient scarless genome editing in stem cells using CORRECT.
    Kwart D; Paquet D; Teo S; Tessier-Lavigne M
    Nat Protoc; 2017 Feb; 12(2):329-354. PubMed ID: 28102837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted Gene Editing in Human Pluripotent Stem Cells Using Site-Specific Nucleases.
    Merkert S; Martin U
    Adv Biochem Eng Biotechnol; 2018; 163():169-186. PubMed ID: 29124278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient CRISPR-Cas9-mediated generation of knockin human pluripotent stem cells lacking undesired mutations at the targeted locus.
    Merkle FT; Neuhausser WM; Santos D; Valen E; Gagnon JA; Maas K; Sandoe J; Schier AF; Eggan K
    Cell Rep; 2015 May; 11(6):875-883. PubMed ID: 25937281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient Gene Editing of Human Induced Pluripotent Stem Cells Using CRISPR/Cas9.
    Yumlu S; Bashir S; Stumm J; Kühn R
    Methods Mol Biol; 2019; 1961():137-151. PubMed ID: 30912045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the potential of genome editing CRISPR-Cas9 technology.
    Singh V; Braddick D; Dhar PK
    Gene; 2017 Jan; 599():1-18. PubMed ID: 27836667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR/Cas9-mediated correction of human genetic disease.
    Men K; Duan X; He Z; Yang Y; Yao S; Wei Y
    Sci China Life Sci; 2017 May; 60(5):447-457. PubMed ID: 28534256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Method for Genome Editing in Human Pluripotent Stem Cells.
    Smith C; Ye Z; Cheng L
    Cold Spring Harb Protoc; 2016 Apr; 2016(4):pdb.prot090217. PubMed ID: 27037073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-Strand Annealing Plays a Major Role in Double-Strand DNA Break Repair following CRISPR-Cas9 Cleavage in
    Zhang WW; Matlashewski G
    mSphere; 2019 Aug; 4(4):. PubMed ID: 31434745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and Validation of CRISPR/Cas9 Systems for Targeted Gene Modification in Induced Pluripotent Stem Cells.
    Lee CM; Zhu H; Davis TH; Deshmukh H; Bao G
    Methods Mol Biol; 2017; 1498():3-21. PubMed ID: 27709565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TALEN- and CRISPR-enhanced DNA homologous recombination for gene editing in zebrafish.
    Zhang Y; Huang H; Zhang B; Lin S
    Methods Cell Biol; 2016; 135():107-20. PubMed ID: 27443922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pipeline for the Generation and Characterization of Transgenic Human Pluripotent Stem Cells Using the CRISPR/Cas9 Technology.
    Mianné J; Bourguignon C; Nguyen Van C; Fieldès M; Nasri A; Assou S; De Vos J
    Cells; 2020 May; 9(5):. PubMed ID: 32466123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.